Publications

1. Mak E, Przybelski SA, Wiste HJ, Fought AJ, Schwarz CG, Senjem ML, Jack CR Jr, Lowe VJ, Petersen RC, Boeve BF, O'Brien JT, Kantarci K, Alzheimer's Disease Neuroimaging Initiative. Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of alpha-synuclein seed amplification assay and FDG-PET. Alzheimers Dement. 2025 Feb; 21 (2):e14571
   View PubMed
2. Dounavi ME, Mak E, Operto G, Muniz-Terrera G, Bridgeman K, Koychev I, Malhotra P, Naci L, Lawlor B, Su L, Falcon C, Ritchie K, Ritchie CW, Gispert JD, O'Brien JT. Texture-based morphometry in relation to apolipoprotein epsilon4 genotype, ageing and sex in a midlife population. Hum Brain Mapp. 2024 Aug 1; 45 (11):e26798
   View PubMed
3. Mak E, Reid RI, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Raghavan S, Vemuri P, Jack CR Jr, Min HK, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Jones DT, Botha H, St Louis EK, Knopman DS, Ramanan VK, Dickson DW, Graff-Radford NR, Ferman TJ, Petersen RC, Lowe VJ, Boeve BF, O'Brien JT, Kantarci K. Influences of amyloid-ß and tau on white matter neurite alterations in dementia with Lewy bodies. NPJ Parkinsons Dis. 2024 Apr 03; 10(1):76.
   View PubMed
4. Visser M, O'Brien JT, Mak E. In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review. Ageing Res Rev. 2024 Feb; 94:102197 Epub 2024 Jan 22
   View PubMed
5. Mak E, Dounavi ME, Operto G, Ziukelis ET, Jones PS, Low A, Swann P, Newton C, Muniz Terrera G, Malhotra P, Koychev I, Falcon C, Mackay C, Lawlor B, Naci L, Wells K, Ritchie C, Ritchie K, Su L, Gispert JD, O'Brien JT, PREVENT-Dementia and ALFA studies. APOE varepsilon4 exacerbates age-dependent deficits in cortical microstructure. Brain Commun. 2024; 6 (1):fcad351 Epub 2024 Feb 21
   View PubMed
6. Stefaniak JD, Mak E, Su L, Carter SF, Dounavi ME, Muniz Terrera G, Bridgeman K, Ritchie K, Lawlor B, Naci L, Koychev I, Malhotra P, Ritchie CW, O'Brien JT. Brain age gap, dementia risk factors and cognition in middle age. Brain Commun. 2024; 6 (6):fcae392 Epub 2024 Nov 19
   View PubMed
7. Ritchie CW, Bridgeman K, Gregory S, O'Brien JT, Danso SO, Dounavi ME, Carriere I, Driscoll D, Hillary R, Koychev I, Lawlor B, Naci L, Su L, Low A, Mak E, Malhotra P, Manson J, Marioni R, Murphy L, Ntailianis G, Stewart W, Muniz-Terrera G, Ritchie K. The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia. Brain Commun. 2024; 6 (3):fcae189 Epub 2024 May 31
   View PubMed
8. Whiteside DJ, Holland N, Tsvetanov KA, Mak E, Malpetti M, Savulich G, Jones PS, Naessens M, Rouse MA, Fryer TD, Hong YT, Aigbirhio FI, Mulroy E, Bhatia KP, Rittman T, O'Brien JT, Rowe JB. Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration. Nat Commun. 2023 Dec 20; 14 (1):8458
   View PubMed
9. Dounavi ME, Mak E, Swann P, Low A, Muniz-Terrera G, McKeever A, Pope M, Williams GB, Wells K, Lawlor B, Naci L, Malhotra P, Mackay C, Koychev I, Ritchie K, Su L, Ritchie CW, O'Brien JT. Differential association of cerebral blood flow and anisocytosis in APOE epsilon4 carriers at midlife. J Cereb Blood Flow Metab. 2023 Oct; 43 (10):1672-1684 Epub 2023 May 03
   View PubMed
10. Savulich G, Ferry-Bolder E, Lim TV, Mak E, Ersche KD. The 'Resilient Brain': challenging key characteristics associated with the concept of resilience. Psychol Med. 2023 Oct; 53 (14):6933-6936 Epub 2023 Jan 25
    View PubMed
11. Malpetti M, Cope TE, Street D, Jones PS, Hezemans FH, Mak E, Tsvetanov KA, Rittman T, Bevan-Jones WR, Patterson K, Passamonti L, Fryer TD, Hong YT, Aigbirhio FI, O'Brien JT, Rowe JB. Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia. Brain. 2023 Aug 1; 146 (8):3221-3231
    View PubMed
12. Mak E, Zhang L, Tan CH, Reilhac A, Shim HY, Wen MOQ, Wong ZX, Chong EJY, Xu X, Stephenson M, Venketasubramanian N, Zhou JH, O'Brien JT, Chen CL. Longitudinal associations between beta-amyloid and cortical thickness in mild cognitive impairment. Brain Commun. 2023; 5 (4):fcad192 Epub 2023 July 04
    View PubMed
13. Grigorova M, Mak E, Brown SSG, Beresford-Webb J, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Tudorascu D, Cohen A, Christian BT, Ances B, Handen BL, Laymon CM, Klunk WE, Clare ICH, Holland AJ, Zaman SH. Amyloid- beta and tau deposition influences cognitive and functional decline in Down syndrome. Neurobiol Aging. 2022 Nov; 119:36-45 Epub 2022 July 21
    View PubMed
14. Dounavi ME, Newton C, Jenkins N, Mak E, Low A, Muniz-Terrera G, Williams GB, Lawlor B, Naci L, Malhotra P, Mackay CE, Koychev I, Ritchie K, Ritchie CW, Su L, O'Brien JT. Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study. J Neurol. 2022 Aug; 269 (8):4299-4309 Epub 2022 Mar 13
    View PubMed
15. Ziukelis ET, Mak E, Dounavi ME, Su L, T O'Brien J. Fractal dimension of the brain in neurodegenerative disease and dementia: A systematic review. Ageing Res Rev. 2022 Aug; 79:101651 Epub 2022 May 25
    View PubMed
16. Brown SSG, Mak E, Clare I, Grigorova M, Beresford-Webb J, Walpert M, Jones E, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Tudorascu D, Cohen A, Christian BT, Handen BL, Klunk WE, Menon DK, Nestor PJ, Holland AJ, Zaman SH. Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down's syndrome. Neurobiol Aging. 2022 Jul; 115:112-121 Epub 2022 Mar 04
    View PubMed
17. Malpetti M, Kaalund SS, Tsvetanov KA, Rittman T, Briggs M, Allinson KSJ, Passamonti L, Holland N, Jones PS, Fryer TD, Hong YT, Kouli A, Bevan-Jones WR, Mak E, Savulich G, Spillantini MG, Aigbirhio FI, Williams-Gray CH, O'Brien JT, Rowe JB. In Vivo (18)F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy. J Nucl Med. 2022 Jul; 63 (7):1052-1057 Epub 2021 Nov 18
    View PubMed
18. Chouliaras L, Thomas A, Malpetti M, Donaghy P, Kane J, Mak E, Savulich G, Prats-Sedano MA, Heslegrave AJ, Zetterberg H, Su L, Rowe JB, O'Brien JT. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2022 Jun; 93 (6):651-658 Epub 2022 Jan 25
    View PubMed
19. Low A, Prats-Sedano MA, Stefaniak JD, McKiernan EF, Carter SF, Douvani ME, Mak E, Su L, Stupart O, Muniz G, Ritchie K, Ritchie CW, Markus HS, O'Brien JT. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study. J Neurol Neurosurg Psychiatry. 2022 May; 93 (5):481-490 Epub 2022 Feb 08
    View PubMed
20. Holland N, Malpetti M, Rittman T, Mak EE, Passamonti L, Kaalund SS, Hezemans FH, Jones PS, Savulich G, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study. Brain. 2022 Mar 29; 145 (1):340-348
    View PubMed
21. Dounavi ME, Low A, McKiernan EF, Mak E, Muniz-Terrera G, Ritchie K, Ritchie CW, Su L, O'Brien JT. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE epsilon4 carriers: The PREVENT-Dementia study. J Cereb Blood Flow Metab. 2021 Nov; 41 (11):2844-2855 Epub 2021 June 02
    View PubMed
22. Kucikova L, Goerdten J, Dounavi ME, Mak E, Su L, Waldman AD, Danso S, Muniz-Terrera G, Ritchie CW. Resting-state brain connectivity in healthy young and middle-aged adults at risk of progressive Alzheimer's disease. Neurosci Biobehav Rev. 2021 Oct; 129:142-153 Epub 2021 July 24
    View PubMed
23. Nicastro N, Mak E, Surendranathan A, Rittman T, Rowe JB, O'Brien JT. Altered structural connectivity networks in dementia with lewy bodies. Brain Imaging Behav. 2021 Oct; 15 (5):2445-2453 Epub 2021 Jan 29
    View PubMed
24. Malpetti M, Holland N, Jones PS, Ye R, Cope TE, Fryer TD, Hong YT, Savulich G, Rittman T, Passamonti L, Mak E, Aigbirhio FI, O'Brien JT, Rowe JB. Synaptic density in carriers of C9orf72 mutations: a [(11) C]UCB-J PET study. Ann Clin Transl Neurol. 2021 Jul; 8 (7):1515-1523 Epub 2021 June 16
    View PubMed
25. Mak E, Holland N, Jones PS, Savulich G, Low A, Malpetti M, Kaalund SS, Passamonti L, Rittman T, Romero-Garcia R, Manavaki R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies. Neurobiol Aging. 2021 May; 101:187-198 Epub 2021 Jan 30
    View PubMed
26. Mak E, Nicastro N, Malpetti M, Savulich G, Surendranathan A, Holland N, Passamonti L, Jones PS, Carter SF, Su L, Hong YT, Fryer TD, Williams GB, Aigbirhio F, Rowe JB, O'Brien JT. Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography. Neurobiol Aging. 2021 May; 101:172-180 Epub 2020 Nov 14
    View PubMed
27. Beresford-Webb JA, Mak E, Grigorova M, Daffern SJ, Holland AJ, Zaman SH. Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS). BJPsych Open. 2021 Apr 13; 7 (3):e79
    View PubMed
28. Mak E, Dounavi ME, Low A, Carter SF, McKiernan E, Williams GB, Jones PS, Carriere I, Muniz GT, Ritchie K, Ritchie C, Su L, O'Brien JT. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study. Neuroimage. 2021 Apr 1; 229:117749 Epub 2021 Jan 14
    View PubMed
29. Low A, Su L, Stefaniak JD, Mak E, Dounavi ME, Muniz-Terrera G, Ritchie K, Ritchie CW, Markus HS, O'Brien JT. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study. Neurobiol Aging. 2021 Feb; 98:124-133 Epub 2020 Nov 02
    View PubMed
30. Mak E, Grigorova M, Beresford-Webb J, Malpetti M, Walpert M, Brown S, Jones E, Clare I, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Menon DK, Nestor PJ, Holland AJ, Zaman SH. Measuring cerebral perfusion with [(11)C]-PiB R1 in Down syndrome: associations with amyloid burden and longitudinal cognitive decline. Brain Commun. 2021; 3 (1):fcaa198 Epub 2020 Nov 18
    View PubMed
31. Mak E, Kouli A, Holland N, Nicastro N, Savulich G, Surendranathan A, Malpetti M, Manavaki R, Hong YT, Fryer TD, Aigbirhio F, Rowe JB, O'Brien JT, Williams-Gray CH. [(18)F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases. Brain Commun. 2021; 3 (3):fcab177 Epub 2021 Aug 28
    View PubMed
32. Ochsner M, Mak E, Ersche KD. Detecting Small Vessel Pathology in Cocaine Use Disorder. Front Neurosci. 2021; 15:827329 Epub 2022 Feb 10
    View PubMed
33. Nicastro N, Malpetti M, Mak E, Williams GB, Bevan-Jones WR, Carter SF, Passamonti L, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT. Gray matter changes related to microglial activation in Alzheimer's disease. Neurobiol Aging. 2020 Oct; 94:236-242 Epub 2020 June 17
    View PubMed
34. Low A, Mak E, Malpetti M, Passamonti L, Nicastro N, Stefaniak JD, Savulich G, Chouliaras L, Su L, Rowe JB, Markus HS, O'Brien JT. In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2020 Sep 11; 92 (1):45-52 Epub 2020 Sept 11
    View PubMed
35. McKiernan EF, Mak E, Dounavi ME, Wells K, Ritchie C, Williams G, Su L, O'Brien J. Regional hyperperfusion in cognitively normal APOE epsilon4 allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohort. J Neurol Neurosurg Psychiatry. 2020 Aug; 91 (8):861-866 Epub 2020 June 25
    View PubMed
36. Dounavi ME, Mak E, Wells K, Ritchie K, Ritchie CW, Su L, O' Brien JT. Volumetric alterations in the hippocampal subfields of subjects at increased risk of dementia. Neurobiol Aging. 2020 Jul; 91:36-44 Epub 2020 Mar 14
    View PubMed
37. Zhang L, Mak E, Reilhac A, Shim HY, Ng KK, Ong MQW, Ji F, Chong EJY, Xu X, Wong ZX, Stephenson MC, Venketasubramanian N, Tan BY, O'Brien JT, Zhou JH, Chen CLH, Alzheimer's Disease Neuroimaging Initiative. Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly. Hum Brain Mapp. 2020 Jun 1; 41 (8):2037-2047 Epub 2020 Jan 14
    View PubMed
38. Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, Mak E, Nicastro N, Bevan-Jones WR, Su L, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease. Brain. 2020 May 1; 143 (5):1588-1602
    View PubMed
39. Low A, Mak E, Stefaniak JD, Malpetti M, Nicastro N, Savulich G, Chouliaras L, Markus HS, Rowe JB, O'Brien JT. Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage. Front Neurosci. 2020; 14:238 Epub 2020 Mar 19
    View PubMed
40. Nicastro N, Mak E, Williams GB, Surendranathan A, Bevan-Jones WR, Passamonti L, Vazquez Rodriguez P, Su L, Arnold R, Fryer TD, Hong YT, Aigbirhio FI, Rowe JB, O'Brien JT. Correlation of microglial activation with white matter changes in dementia with Lewy bodies. Neuroimage Clin. 2020; 25:102200 Epub 2020 Jan 28
    View PubMed
41. Brown SSG, Mak E, Zaman S. Multi-Modal Imaging in Down's Syndrome: Maximizing Utility Through Innovative Neuroimaging Approaches. Front Neurol. 2020; 11:629463 Epub 2021 Jan 07
    View PubMed
42. Nicastro N, Holland N, Savulich G, Carter SF, Mak E, Hong YT, Milicevic Sephton S, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. (11)C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies. Eur J Hybrid Imaging. 2020; 4 (1):25 Epub 2020 Dec 22
    View PubMed
43. Nicastro N, Malpetti M, Cope TE, Bevan-Jones WR, Mak E, Passamonti L, Rowe JB, O'Brien JT. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia. J Alzheimers Dis. 2020; 76 (1):331-340
    View PubMed
44. Low A, Mak E, Malpetti M, Chouliaras L, Nicastro N, Su L, Holland N, Rittman T, Rodriguez PV, Passamonti L, Bevan-Jones WR, Jones PS, Rowe JB, O'Brien JT. Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features. Alzheimers Dement (Amst). 2019 Dec; 11:690-699 Epub 2019 Oct 01
    View PubMed
45. Mak E, Bickerton A, Padilla C, Walpert MJ, Annus T, Wilson LR, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Christian BT, Handen BL, Klunk WE, Menon DK, Nestor PJ, Zaman SH, Holland AJ. Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report. Alzheimers Dement (Amst). 2019 Dec; 11:654-658 Epub 2019 Nov 25
    View PubMed
46. Nicastro N, Surendranathan A, Mak E, Rowe JB, O'Brien JT. (11) C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia. Ann Clin Transl Neurol. 2019 Oct; 6 (10):2133-2136 Epub 2019 Sept 10
    View PubMed
47. Low A, Mak E, Rowe JB, Markus HS, O'Brien JT. Inflammation and cerebral small vessel disease: A systematic review. Ageing Res Rev. 2019 Aug; 53:100916 Epub 2019 June 10
    View PubMed
48. Mak E, Padilla C, Annus T, Wilson LR, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Menon DK, Nestor PJ, Zaman SH, Holland AJ. Delineating the topography of amyloid-associated cortical atrophy in Down syndrome. Neurobiol Aging. 2019 Aug; 80:196-202 Epub 2019 Mar 05
    View PubMed
49. Mak E, Surendranathan A, Nicastro N, Aigbirhio F, Rowe J, O'Brien J. Imaging Tau, Neuroinflammation, and Abeta in Dementia With Lewy Bodies: A Deep-Phenotyping Case Report. Mov Disord Clin Pract. 2019 Jan; 6 (1):77-80 Epub 2018 Nov 08
    View PubMed
50. Mak E, Donaghy PC, McKiernan E, Firbank MJ, Lloyd J, Petrides GS, Thomas AJ, O'Brien JT. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies. Neurobiol Aging. 2019 Jan; 73:74-81 Epub 2018 Sept 12
    View PubMed
51. Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vazquez Rodriguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. Early microglial activation and peripheral inflammation in dementia with Lewy bodies. Brain. 2018 Dec 1; 141 (12):3415-3427
    View PubMed
52. Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study. J Neurol. 2018 Jul; 265 (7):1528-1539 Epub 2018 Apr 25
    View PubMed
53. Passamonti L, Rodriguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. [(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. Neurology. 2018 May 29; 90 (22):e1989-e1996 Epub 2018 Apr 27
    View PubMed
54. Stefaniak JD, Su L, Mak E, Sheikh-Bahaei N, Wells K, Ritchie K, Waldman A, Ritchie CW, O'Brien JT. Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease. Alzheimers Dement. 2018 Feb; 14 (2):253-258 Epub 2017 Nov 21
    View PubMed
55. Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vazquez Rodriguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT. In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease. Alzheimers Dement (Amst). 2018; 10:678-687 Epub 2018 Sept 17
    View PubMed
56. Habib M, Mak E, Gabel S, Su L, Williams G, Waldman A, Wells K, Ritchie K, Ritchie C, O'Brien JT. Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease. Ageing Res Rev. 2017 Jul; 36:88-104 Epub 2017 Mar 22
    View PubMed
57. Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease. Neurobiol Aging. 2017 Jul; 55:78-90 Epub 2017 Mar 16
    View PubMed
58. Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O'Brien JT. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Ageing Res Rev. 2017 Jul; 36:50-63 Epub 2017 Mar 15
    View PubMed
59. Mak E, Gabel S, Mirette H, Su L, Williams GB, Waldman A, Wells K, Ritchie K, Ritchie C, O'Brien J. Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes. Ageing Res Rev. 2017 May; 35:250-264 Epub 2016 Oct 21
    View PubMed
60. Mak E, Gabel S, Su L, Williams GB, Arnold R, Passamonti L, Vazquez Rodriguez P, Surendranathan A, Bevan-Jones WR, Rowe JB, O'Brien JT. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies. Int Psychogeriatr. 2017 Apr; 29 (4):545-555 Epub 2017 Jan 16
    View PubMed
61. Passamonti L, Vazquez Rodriguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, Sami S, Cope TE, Bevan-Jones WR, Jones PS, Arnold R, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy. Brain. 2017 Mar 1; 140 (3):781-791
    View PubMed
62. Bevan-Jones WR, Surendranathan A, Passamonti L, Vazquez Rodriguez P, Arnold R, Mak E, Su L, Coles JP, Fryer TD, Hong YT, Williams G, Aigbirhio F, Rowe JB, O'Brien JT. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses. BMJ Open. 2017 Jan 7; 7 (1):e013187 Epub 2017 Jan 07
    View PubMed
63. Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, Tan LC, Kandiah N. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease. Neuroimage Clin. 2017; 14:37-42 Epub 2016 Dec 12
    View PubMed
64. Mak E, Colloby SJ, Thomas A, O'Brien JT. The segregated connectome of late-life depression: a combined cortical thickness and structural covariance analysis. Neurobiol Aging. 2016 Dec; 48:212-221 Epub 2016 Aug 24
    View PubMed
65. Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Tan L, Kandiah N. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease. Parkinsonism Relat Disord. 2016 Oct; 31:34-40 Epub 2016 June 30
    View PubMed
66. Mole TB, Mak E, Chien Y, Voon V. Dissociated Accumbens and Hippocampal Structural Abnormalities across Obesity and Alcohol Dependence. Int J Neuropsychopharmacol. 2016 Sep; 19 (9) Epub 2016 Sept 21
    View PubMed
67. Firbank MJ, Watson R, Mak E, Aribisala B, Barber R, Colloby SJ, He J, Blamire AM, O'Brien JT. Longitudinal diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease. Parkinsonism Relat Disord. 2016 Mar; 24:76-80 Epub 2016 Jan 06
    View PubMed
68. Mak E, Su L, Williams GB, Watson R, Firbank M, Blamire A, O'Brien J. Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease. Am J Geriatr Psychiatry. 2016 Feb; 24 (2):136-43 Epub 2015 June 25
    View PubMed
69. Mak E, Chin R, Ng LT, Yeo D, Hameed S. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry. 2015 Dec; 30 (12):1207-14 Epub 2015 Mar 09
    View PubMed
70. Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain. 2015 Oct; 138 (Pt 10):2974-86 Epub 2015 July 14
    View PubMed
71. Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease. J Neuroimaging. 2015 Sep-Oct; 25 (5):754-60 Epub 2015 Mar 05
    View PubMed
72. Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O'Brien JT. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry. 2015 Aug 1; 172 (8):731-42 Epub 2015 June 18
    View PubMed
73. Mak E, Su L, Williams GB, O'Brien JT. Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease. Parkinsonism Relat Disord. 2015 Aug; 21 (8):862-70 Epub 2015 May 19
    View PubMed
74. Mak E, Su L, Williams GB, Watson R, Firbank MJ, Blamire AM, O'Brien JT. Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease. Neurobiol Aging. 2015 Apr; 36 (4):1743-1750 Epub 2015 Jan 08
    View PubMed
75. Mak E, Su L, Williams GB, Watson R, Firbank M, Blamire AM, O'Brien JT. Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies. Neuroimage Clin. 2015; 7:456-62 Epub 2015 Feb 07
    View PubMed
76. Kandiah N, Zainal NH, Narasimhalu K, Chander RJ, Ng A, Mak E, Au WL, Sitoh YY, Nadkarni N, Tan LC. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease. Parkinsonism Relat Disord. 2014 Nov; 20 (11):1203-8 Epub 2014 Sept 16
    View PubMed
77. Mak E, Zhou J, Tan LC, Au WL, Sitoh YY, Kandiah N. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy. J Neurol Neurosurg Psychiatry. 2014 May; 85 (5):576-80 Epub 2013 Oct 16
    View PubMed
78. Mak E, Su L, Williams GB, O'Brien JT. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther. 2014; 6 (2):18 Epub 2014 Apr 09
    View PubMed
79. Kandiah N, Goh O, Mak E, Marmin M, Ng A. Carotid stenosis: a risk factor for cerebral white-matter disease. J Stroke Cerebrovasc Dis. 2014 Jan; 23 (1):136-9 Epub 2012 Dec 21
    View PubMed
80. Kandiah N, Mak E, Ng A, Huang S, Au WL, Sitoh YY, Tan LC. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat Disord. 2013 Jul; 19 (7):680-3 Epub 2013 Apr 24
    View PubMed